DK3745870T3 - Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom - Google Patents

Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom Download PDF

Info

Publication number
DK3745870T3
DK3745870T3 DK19705706.0T DK19705706T DK3745870T3 DK 3745870 T3 DK3745870 T3 DK 3745870T3 DK 19705706 T DK19705706 T DK 19705706T DK 3745870 T3 DK3745870 T3 DK 3745870T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
treatment
bowel syndrome
irritable bowel
combination product
Prior art date
Application number
DK19705706.0T
Other languages
English (en)
Inventor
Barry Kiely
Eileen Frances Murphy
David Groeger
Original Assignee
Prec Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec Group Limited filed Critical Prec Group Limited
Application granted granted Critical
Publication of DK3745870T3 publication Critical patent/DK3745870T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204Probiotics, living bacteria to be ingested for action in the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/533Longum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK19705706.0T 2018-01-29 2019-01-29 Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom DK3745870T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18153992 2018-01-29
EP18190595 2018-08-23
EP18190598 2018-08-23
PCT/EP2019/052134 WO2019145570A1 (en) 2018-01-29 2019-01-29 A combination product for prophylaxis and treatment of irritable bowel syndrome

Publications (1)

Publication Number Publication Date
DK3745870T3 true DK3745870T3 (da) 2023-02-20

Family

ID=65443825

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19705706.0T DK3745870T3 (da) 2018-01-29 2019-01-29 Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom

Country Status (7)

Country Link
US (3) US11400123B2 (da)
EP (3) EP4154722A1 (da)
KR (2) KR102760825B1 (da)
CN (2) CN112074193A (da)
DK (1) DK3745870T3 (da)
ES (1) ES2933999T3 (da)
WO (1) WO2019145570A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201807143T4 (tr) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
EP4147704A1 (en) * 2018-01-29 2023-03-15 PrecisionBiotics Group Limited Bifidobacterium longum ncimb 41676
EP4666871A3 (en) * 2018-01-29 2026-03-11 PrecisionBiotics Group Limited Bifidobacterium longum for improving sleep quality
EP4285997A4 (en) 2021-01-26 2025-04-16 Megmilk Snow Brand Co. Ltd. COMPOSITION TO IMPROVE JOINT FUNCTION
CN114917255A (zh) * 2022-06-09 2022-08-19 比菲德(北京)生物科技有限公司 一种可缓解自闭症并调节情绪的益生菌粉及其应用
CN117417860B (zh) * 2023-10-20 2026-03-27 江南大学 一株缓解肠易激综合征的短双歧杆菌及其应用
CN117736943B (zh) * 2024-02-20 2024-05-24 山东中科嘉亿生物工程有限公司 一种改善肠易激综合征的复合菌剂及其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
EP1743633B1 (en) 2004-04-06 2010-08-18 Taiyokagaku Co., Ltd. Use of a combination of theanine and serotonin for sleep disorders
EP1865795A1 (en) * 2005-04-08 2007-12-19 Alimentary Health Limited Methods of use of orally administered probiotic bifidobacteria for human beauty benefits
JP2007169200A (ja) 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
EP2134833B1 (en) * 2007-03-28 2016-03-09 Alimentary Health Limited Probiotic bifidobacterium strain
WO2008135959A1 (en) * 2007-05-04 2008-11-13 Alimentary Health Limited An exopolysaccharide
CN102202527B (zh) 2008-11-03 2014-12-31 雀巢产品技术援助有限公司 包含益生菌并改善睡眠模式的营养组合物
MX356598B (es) 2008-11-11 2018-06-04 Alimentary Health Ltd Bifidobacterium longum.
US20110027412A1 (en) * 2009-07-31 2011-02-03 Kris Eugene Spence Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health
EP2498789B1 (en) * 2009-11-11 2016-06-22 Alimentary Health Limited Probiotic bifidobacterium strain
EP2481299B1 (en) * 2011-01-31 2016-12-07 Dr. Fischer Gesundheitsprodukte GmbH Bifidobacterium bifidum strains for application in gastrointestinal diseases
US20150125548A1 (en) 2011-11-14 2015-05-07 Requis Pharmaceuticals Inc. Combination nutritional and nutraceutical products
EP3097182A1 (en) * 2014-01-24 2016-11-30 The Procter & Gamble Company Filaments comprising a microorganism and method for making same
EP3124031B1 (en) 2014-03-25 2020-12-30 Kabushiki Kaisha Yakult Honsha Sleep quality improver
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
JP6637725B2 (ja) 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び/又は治療剤
SG11201809593YA (en) 2016-07-01 2018-11-29 Nestec Sa Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
CN106923345B (zh) * 2017-03-19 2021-02-26 北京罗诺强施医药技术研发中心有限公司 稳定的益生菌组合物
MX2020007946A (es) 2018-01-29 2021-02-09 Prec Group Limited Un producto de combinacion para profilaxis y tratamiento de sindrome de intestino irritable.

Also Published As

Publication number Publication date
EP4154722A1 (en) 2023-03-29
KR20250021602A (ko) 2025-02-13
WO2019145570A1 (en) 2019-08-01
US20220387523A1 (en) 2022-12-08
US20200289587A1 (en) 2020-09-17
EP3745870A1 (en) 2020-12-09
EP3745870B1 (en) 2022-11-30
CN116492376A (zh) 2023-07-28
CN112074193A (zh) 2020-12-11
ES2933999T3 (es) 2023-02-15
KR102760825B1 (ko) 2025-02-03
US20230405061A1 (en) 2023-12-21
EP4706767A2 (en) 2026-03-11
KR20200116106A (ko) 2020-10-08
US11400123B2 (en) 2022-08-02
EP4706767A3 (en) 2026-03-25

Similar Documents

Publication Publication Date Title
DK3745870T3 (da) Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom
LT3939658T (lt) Pakeistasis benzopirolas ir struktūriškai susiję komplemento inhibitoriai
DK3478811T3 (da) Rengøringssammensætninger og anvendelser deraf
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
DK3600270T3 (da) Forbindelser og sammensætninger til behandling af hæmatologiske lidelser
DK3185868T3 (da) Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3745872T3 (da) Kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom
DK3294740T3 (da) Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion
DK3723768T3 (da) Forbindelser til behandling og forebyggelse af patologier medieret af ekstracellulære histoner
IL282311A (en) Use of reboxetine to treat narcolepsy
DK3807316T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
EP3765610A4 (en) MICRO-RNA AND OBESITY
DK3386507T3 (da) Metoder og sammensætninger til behandling af mavesår
DK3752506T3 (da) Pyrimidinderivater til forebyggelse og behandling af bakterielle infektioner
DK3966226T3 (da) Masp-hæmmende forbindelser og anvendelser deraf
DK3743064T3 (da) Behandling af proteinuri
EP3784052C0 (en) COOKING PROCESS
DK3484474T3 (da) Phenothiazinforbindelser til behandlingen af ribosomale lidelser og ribosomopatier
DK3383403T3 (da) Aminofosfonisk derivat til forebyggelse og behandling af øjesmerter
DK3319422T3 (da) Sammensætninger og fremgangsmåder til bekæmpelsen af leddyr